2031 - 2040 of 4301 Drugs
Entex La (guaifenesin and phenylephrine)
Entex LA (phenylephrine hydrochloride and guaifenesin) is a combination of a decongestant and an expectorant used to treat stuffy nose and sinus congestion, and to reduce chest congestion caused by the common cold or flu. Entex LA is available in generic form.
Entex Pse (pseudoephedrine and guaifenesin)
Entex PSE (pseudoephedrine and guaifenesin) is a combination decongestant and expectorant used to treat stuffy nose, sinus congestion, and cough caused by allergies or the common cold. Entex PSE is available in generic form.
Rozlytrek (entrectinib capsules)
Rozlytrek (entrectinib) is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive; and adult and pediatric patients 12 years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have progressed following treatment or have no satisfactory alternative therapy.
Entresto (sacubitril and valsartan film-coated tablets for oral administration)
Entresto (sacubitril and valsartan) is a combination of a neprilysin inhibitor and an angiotensin II receptor blocker indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.
Entyvio (vedolizumab for injection, for intravenous use)
Entyvio (vedolizumab) is an IgG1 monoclonal antibody used to treat moderate to severe active ulcerative colitis (UC) and moderate to severe active Crohn's disease (CD).
Enulose (lactulose solution)
Enulose (lactulose solution) is a synthetic disaccharide in solution form used to prevent and treat portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma.
Envarsus XR (tacrolimus extended-release tablets)
Envarsus XR (tacrolimus extended-release tablets) is a calcineurin-inhibitor immunosuppressant indicated to prevent organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations in combination with other immunosuppressants.